Therapeutically active fused pyrimidine derivatives
US9227984B2 · kind B2 · utility
1Cited by
0References
11Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 15, 2012 |
| Grant date | Jan 5, 2016 |
| Priority date | — |
| Expiry date | Sep 10, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A series of monocyclic or bicyclic diamine-substituted thieno[2,3-d]pyrimidine and isothiazolo[5,4-d]pyrimidine derivatives are beneficial in the treatment and/or prevention of various human ailments, including inflammatory, autoimmune and oncological disorders; viral diseases; and organ and cell transplant rejection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.